ATOPICATM (cyclosporine capsules) USP MODIFIED is indicated for the control of atopic dermatitis in dogs weighing at least 4 pounds.
IMPORTANT SAFETY INFORMATION FOR DOGS - ATOPICATM (cyclosporine capsules) USP MODIFIED: Do not use Atopica in dogs with a history of neoplasia, with a hypersensitivity to cyclosporine, or in reproducing dogs.Atopica is a systemic immunosuppressant that may increase susceptibility to infection and development of neoplasia.For use only in dogs. Capsules should not be broken or opened.Wear gloves during administration and wash hands after administration.Gastrointestinal problems and gingival hyperplasia may occur at the initial dose. Safety and effectiveness has not been established in dogs less than 6 months or 4 lbs. Use with caution in dogs with diabetes mellitus or renal insufficiency, and with drugs that affect the P-450 pathway. Killed vaccines are recommended. The most common adverse events are vomiting and diarrhea. Please see product insert for full prescribing information.
ATOPICATM for Cats (cyclosporine oral solution) USP MODIFIED is indicated for the control of feline allergic dermatitis as manifested by excoriations (including facial and neck), military dermatitis, eosinophilic plaques, and self-induced alopecia in cats at least 6 months of age and at least 3 lbs in body weight.
IMPORTANT SAFETY INFORMATION ATOPICATM FOR CATS (cyclosporine oral solution) USP MODIFIED: Do not use in cats with a history or suspicion of malignant disorders, feline leukemia virus (FeLV) or feline immunodeficiency virus (FIV) infection, or hypersensitivity to cyclosporine. Atopica is a systemic immunosuppressant that may increase susceptibility to infection, development of neoplasia, and decrease response to vaccination. Persistent, progressive weight loss may result in hepatic lipidosis; monitoring of body weight is recommended. For use only in cats. Wash hands after administration. People with known hypersensitivity should avoid contact with Atopica. Do not use with other immunosuppressive agents. It is important for cats to avoid exposure to Toxoplasma gondii during treatment. Use with caution in cats with diabetes mellitus or renal insufficiency, and with drugs that affect the P-450 enzyme system. The most common adverse events were vomiting, weight loss, diarrhea or loss of appetite. Please speak with your veterinarian for advice. Please see product insert for full prescribing information.